Phosphatidylinositol 3-Kinase Is a Requirement for Insulin-Like Growth Factor I-Induced Differentiation, but not for Mitogenesis, in Fetal Brown Adipocytes
Angela M. Valverde,
Margarita Lorenzo,
Paloma Navarro and
Manuel Benito
Departamento de Bioquimica y Biologia Molecular II Instituto de
Bioquimica Facultad de Farmacia Universidad Complutense
28040 Madrid, Spain
 |
ABSTRACT
|
---|
In the present study we have examined the role of
phosphatidylinositol 3-kinase (PI 3-kinase) in the insulin-like growth
factor I (IGF-I)-signaling pathways involved in differentiation and in
mitogenesis in fetal rat brown adipocytes. Activation of PI 3-kinase in
response to IGF-I was markedly inhibited by two PI 3-kinase inhibitors
(wortmannin and LY294002) in a dose-dependent manner. IGF-I-stimulated
glucose uptake was also inhibited by both compounds. The expression of
adipogenic-related genes such as fatty acid synthase, malic enzyme,
glycerol 3-phosphate dehydrogenase, and acetylcoenzyme A carboxylase
induced by IGF-I was totally prevented in the presence of IGF-I and any
of those inhibitors, resulting in a marked decrease of the cytoplasmic
lipid content. Moreover, the expression of the thermogenic marker
uncoupling protein induced by IGF-I was also down-regulated in the
presence of wortmannin/LY294002. IGF-I-induced adipogenic- and
thermogenic-related gene expression was only partly inhibited by the
p70S6k inhibitor rapamycin. In addition,
pretreatment of brown adipocytes with either wortmannin or LY294002,
but not with rapamycin, blocked protein kinase C
activation by
IGF-I. In contrast, IGF-I-induced fetal brown adipocyte proliferation
was PI 3-kinase-independent. Our results show for the first time an
essential requirement of PI 3-kinase in the IGF-I-signaling pathways
leading to fetal brown adipocyte differentiation, but not leading to
mitogenesis. In addition, protein kinase C
seems to be a signaling
molecule also involved in the IGF-I differentiation pathways downstream
from PI 3-kinase.
 |
INTRODUCTION
|
---|
Insulin-like growth factor I (IGF-I) has proven to be a mitogenic
peptide with important functions in the regulation of growth,
development, and differentiation in eukaryotic cells (reviewed in Refs.
1 and 2). Although the intracellular events that mediate IGF-I action
are not fully understood, the regulation of both protein and lipid
phosphorylation are thought to play a prominent role. It is assumed,
however, that the signals may merge and diverge at the levels of
several key intermediates that become activated upon binding to its
receptors on the cell surface. The activated IGF-I receptor
phosphorylates a variety of cellular proteins on tyrosine residues. One
of the best studied substrates of the IGF-I/insulin receptor is the
insulin receptor substrate-1 (IRS-1) (3, 4, 5). Tyrosine phosphorylated
IRS-1 binds and activates several signaling molecules, including the
85-kDa subunit of phosphatidylinositol 3-kinase (PI 3-kinase)
(6, 7, 8).
PI 3-kinase is a family of heterodimeric enzymes composed of a p85-
regulatory subunit and a p110 catalytic subunit (9, 10). PI 3-kinase is
a lipid kinase capable of phosphorylating phosphoinositides at the
3'-position of the inositol ring (11), and these lipids have been
postulated as second messengers (11, 12, 13). Although during recent years
much information has beed accumulated on the role of PI 3-kinase
activities in tyrosine kinase receptor signal transduction or vesicle
trafficking, little is known about the possible role of PI 3-kinase in
cell differentiation. In this regard, Kaliman et al. (14)
have recently implicated PI 3-kinase as an essential positive regulator
of terminal differentiation of skeletal muscle cells.
Fetal brown adipocyte primary cultures offer a nonfibroblastic
mesenchymal cell model that has proven to be an excellent system in
which to study both proliferation and differentiation processes
(15, 16, 17, 18, 19) and signal transduction (20). These cells show a high level of
IGF-I receptor mRNA expression and bear a high number of high-affinity
IGF-I binding sites per cell. In fetal brown adipocyte primary
cultures, IGF-I behaved as a mitogen per se in a p21 ras
protein content-dependent manner (15, 17, 21). With regard to
differentiation, rat brown adipocytes differentiate at the end of fetal
life on the basis of two programs: the adipogenic program related to
lipid synthesis and the thermogenic program related to heat production
associated with the expression of the uncoupling protein (UP) to yield
an identifiable and functional tissue at birth (19, 22). The UP
expression constitutes a unique molecular marker that distinguishes
this cell type from any other mammalian adipose cell. Our previous work
has shown that IGF-I, which stimulates PI 3-kinase activity in brown
adipocytes (20), is also capable of inducing the expression of both
adipogenic (23) and thermogenic (17) genes. However, the signal
transduction pathways by which IGF-I is involved in the adipogenic and
thermogenic differentiation of fetal brown adipocytes have not yet been
clarified.
Accordingly, in the present study we demonstrate that treatment of
brown adipocytes with PI 3-kinase inhibitors (wortmannin/LY294002), but
not with p70S6k inhibitor (rapamycin), impaired the
IGF-I-induced effect on the expression of adipogenic- and
thermogenic-related genes, while brown adipocyte proliferation remained
unaltered. Our results show for the first time that other signaling
molecules such as protein kinase C
(PKC
) may be involved in
IGF-I-induced brown adipocyte differentiation process.
 |
RESULTS
|
---|
The Effect of PI 3-Kinase Inhibitors on IGF-I-Induced
IRS-1-Associated PI 3-Kinase Activity in Fetal Brown Adipocytes
We have recently demonstrated the stimulation of PI 3-kinase
enzymatic activity in fetal brown adipocyte primary cultures treated
with IGF-I (20). Wortmannin has proven to be a specific PI 3-kinase
inhibitor that directly binds to, and inhibits, the catalytic (110 kDa)
subunit of PI 3-kinase (24, 25). To establish concentrations of
wortmannin that effectively inhibited PI 3-kinase activity in fetal
brown adipocytes stimulated with IGF-I, quiescent cells were either
stimulated for 5 min with 10 nM IGF-I or preincubated for
15 min with various doses of wortmannin and subsequently stimulated
with 10 nM IGF-I for a further 5 min. Then, whole cell
lysates (600 µg of protein) were subjected to immunoprecipitation
with the anti-IRS-1 antibody, and the resulting immune complexes were
assayed for PI 3-kinase activity as described in Materials and
Methods. As shown in Fig. 1A
(upper
panel), there was a 90% inhibition of IGF-I-stimulated PI 3-kinase
activity when cells were pretreated for 15 min with 10 nM
wortmannin, and total inhibition was observed with the dose of 20
nM.

View larger version (33K):
[in this window]
[in a new window]
|
Figure 1. Effect of Wortmannin and LY294002 on
IGF-I-Stimulated PI 3-Kinase Activity and the Tyrosine Phosphorylation
of the IGF-I Receptor and IRS in Fetal Brown Adipocytes
A, 20-h serum-starved fetal brown adipocytes were incubated for 5 min
at 37 C with 10 nM IGF-I or preincubated for 15 min with
various doses of wortmannin and LY294002 followed by treatment for 5
min with 10 nM IGF-I. Control cells were cultured in the
presence of wortmannin (20 nM) (Cw) or LY294002
(10 µM) (CLY) or received an equivalent
volume of dimethylsulfoxide (DMSO) (C). Cells were lysed and
immunoprecipitated with an anti-IRS-1 antibody. The immune complexes
were washed and immediately used for an in vitro
phosphatidylinositol kinase assay as described in Materials and
Methods. The conversion of phosphatidylinositol to
phosphatidylinositol phosphate in the presence of
[ -32P]ATP was analyzed by TLC. Results are
representative of three independent experiments. B, Cells were treated
for 5 min with 10 nM IGF-I or preincubated for 15 min with
20 nM wortmannin or 10 µM LY204002 and
treated with 10 nM IGF-I for a further 5 min. Control cells
received an equivalent volume of DMSO. Cells were then lysed, and
immunoprecipitates (prepared using the anti-Tyr(P) monoclonal antibody
Py72) were assayed for in vitro protein kinase activity.
The position of the ß-chain of the IGF-I receptor is indicated by an
arrowhead. The positions of molecular weight markers (x
10-3) are shown on the left. C, Cells were
stimulated as described in panel B, immunoprecipitated with anti- p85
antibody, and analyzed by Western blotting with the anti-Tyr(P)
antibody (4G10). The position of IRS (either IRS-1 and/or IRS-2) is
indicated by an arrowhead. The positions of molecular
weight markers (x 10-3) are shown on the
left. The results shown in panels B and C are
representative of at least three independent experiments.
|
|
To substantiate the results obtained with wortmannin, we examined
whether a structurally unrelated compound, LY294002 (a flavonoid
related to quercetin), which has been identified as a specific
inhibitor of PI 3-kinase (26), also inhibits IGF-I-stimulated PI
3-kinase activity in brown adipocytes. As shown in Fig. 1A
(lower panel) LY294002 inhibited IGF-I-stimulated PI
3-kinase activity in a dose-dependent manner: half-maximal effect was
elicited at 2.5 µM concentration and its maximal effect
at 10 µM.
To determine whether the effect of PI 3-kinase inhibitors on
IGF-I-stimulated PI 3-kinase activation was due to alterations in
IGF-I-stimulated receptor phosphorylation and/or phosphotransferase
activity, cells were either stimulated for 5 min with 10 nM
IGF-I or pretreated for 15 min with 20 nM wortmannin or 10
µM LY294002 and subsequently stimulated with 10
nM IGF-I for a further 5 min. Then, lysates were subjected
to immunoprecipitation with the Py72 anti-Tyr(P) antibody and assayed
for in vitro protein kinase activity as described in
Materials and Methods. Figure 1B
is a representative
autoradiogram showing the tyrosine- phosphorylated proteins in the
immunoprecipitates after separation by SDS-PAGE. The presence of 10
nM IGF-I caused a marked increase in the tyrosine
phosphorylation of the 95-kDa band, which corresponds with the
Mr of the ß-subunit of the IGF-I receptor (20), no
phosphorylation being observed in the control cells. The level of
tyrosine phosphorylation of the 95-kDa band did not change
significantly when cells were pretreated with 10 µM
LY294002, this band being even higher upon 20 nM wortmannin
pretreatment.
In the case of the IGF-I receptor, PI 3-kinase is stimulated by
interaction of the p85-regulatory subunit of PI 3-kinase with
tyrosine-phosphorylated IRS-1. To study whether this interaction is
affected by wortmannin and LY294002, we prepared soluble cell lysates
after incubation of cells with both PI 3-kinase inhibitors and IGF-I as
described above. They were next immunoprecipitated with the
p85
antibody and analyzed by Western blotting with the anti-Tyr(P) antibody
(4G10) (Fig. 1C
). After IGF-I stimulation of brown adipocytes, p85 was
associated with tyrosine-phosphorylated IRS (either IRS-1 and/or
IRS-2). Wortmannin (20 nM) increased and LY294002 (10
µM) did not affect IGF-I-stimulated association of the
p85 subunit of PI 3-kinase with IRS-1/IRS-2. Since what is being
measured in this experiment (Fig. 1C
) is both tyrosine phosphorylation
on IRS-1/IRS-2 and its interaction with p85, a possible explanation is
that IRS-1/IRS-2 is phosphorylated to a greater extent in the presence
of wortmannin. This might be associated with the greater tyrosine
kinase activity of the receptor in the presence of wortmannin seen in
Fig. 1B
.
Effect of PI 3-Kinase Inhibitors on IGF-I-Stimulated Glucose
Transport in Brown Adipocytes
Recently it has been demonstrated, in newborn brown fat precursor
cells, that PI 3-kinase is involved in the mechanism of insulin-induced
glucose transport (27). The fact that glucose transport is induced in
fetal brown adipocytes upon IGF-I stimulation (20) prompted us to
investigate whether this effect could be blocked by PI 3-kinase
inhibitors in our fetal primary cells. Quiescent cells were treated for
10 min with 10 nM IGF-I and then incubated for a further 5
min in the presence of 2-deoxy-D(1-3H)glucose. At the same
time, another set of cells were pretreated for 15 min with various
doses of wortmannin or LY294002 and subsequently stimulated with IGF-I
as described above. As shown in Fig. 2A
, IGF-I-induced
glucose transport was supressed by wortmannin in a dose-dependent
manner at the same doses that inhibited PI 3-kinase activity (Fig. 1A
).
This inhibition was statistically significant at 10 and 20
nM concentration of wortmannin, total inhibition being
observed at 20 nM. When cells were pretreated with
LY294002, under the same experimental conditions (Fig. 2B
),
IGF-I-induced glucose transport was also blocked at the same doses that
inhibited PI 3-kinase activity (significant inhibition at 5 and 10
µM concentration and total inhibition at 10
µM).

View larger version (15K):
[in this window]
[in a new window]
|
Figure 2. Effect of PI 3-Kinase Inhibitors on IGF-I-Induced
Glucose Transport in Fetal Brown Adipocytes
Cells (after 20 h of serum deprivation) were treated with 10
nM IGF-I for 10 min or preincubated for 15 min with various
doses of wortmannin (A) or LY294002 (B) and subsequently treated for an
additional 10 min with 10 nM IGF-I. Control cells were
incubated with the corresponding volume of DMSO. Deoxyglucose (dGlc)
transport was measured as described in Materials and
Methods. Results are expressed as disintegrations per min/µg
of protein and are means ± SEM from four independent
experiments. Statistical analysis by Students paired t
test between values in the presence vs. in the absence
of IGF-I is represented by (*) or between IGF-I plus
wortmannin/LY294002 vs. those in the presence of IGF-I
by (ns, ); *, P < 0.01; ns, not
significant.
|
|
PI 3-Kinase Inhibitors Down-Regulate IGF-I-Induced Expression of
Adipogenic Genes in Fetal Brown Adipocytes
IGF-I is a growth factor also involved in adipogenic
differentiation of fetal brown adipocytes (17, 18, 19, 23). To investigate
whether PI 3-kinase plays a role in fetal brown adipocyte
differentiation, we analyzed the effect of PI 3-kinase inhibitors on
the expression of a set of IGF-I-induced adipogenic-related genes.
Fetal brown adipocytes (after 4 h of attachment followed by
culture for 20 h in a serum-free medium) were cultured for a
further 24 h with 10 nM IGF-I both in the absence and
presence of wortmannin (20 nM) or LY294002 (10
µM). As it has been shown that wortmannin is highly
unstable in aqueous solutions (28), we replaced the medium from cells
treated with wortmannin every 6 h. At the end of the culture time
the expression of a set of genes involved in adipogenesis, such as
fatty acid synthase (FAS) (the main adipogenic marker), acetylcoenzyme
A carboxylase (ACC) (the rate-limiting enzyme for long chain fatty acid
synthesis), malic enzyme (ME, a NADPH provider), and
glycerol-3-phosphate dehydrogenase (G3PD, a sterification marker) was
studied by Northern blot, as depicted in the representative experiment
shown in Fig. 3
. In the absence of IGF-I all the mRNA
levels analyzed remained very low, regardless of the presence of PI
3-kinase inhibitors in the culture medium. Upon treatment of cells for
24 h with 10 nM IGF-I, a significant accumulation of
FAS, ME, G3PD, and ACC mRNAs occurred, relative to untreated cells.
Interestingly, when brown adipocytes were cultured in the presence of
IGF-I together with wortmannin or LY294002 (at doses which completely
inhibited PI 3-kinase enzymatic activity), the induction of all the
adipogenic-related mRNAs analyzed was completely prevented, their
expression remaining at the basal levels observed in control cells.

View larger version (45K):
[in this window]
[in a new window]
|
Figure 3. PI 3-Kinase Inhibitors Down-Regulate IGF-I-Induced
Expression of Adipogenic Genes in Fetal Brown Adipocytes
Brown adipocytes after 20 h of serum deprivation were cultured for
a further 24 h with 10 nM IGF-I, both in the absence
and presence of 20 nM wortmannin or 10 µM
LY294002. Control cells were cultured without IGF-I in the absence or
presence of the same concentrations of PI 3-kinase inhibitors. Total
RNA (10 µg) was submitted to Northern blot analysis and hybridized
with labeled FAS, ME, G3PD, ACC, and ß-actin cDNAs. Autoradiograms
from a representative experiment of six are shown.
|
|
Effect of PI 3-Kinase Inhibitors on IGF-I-Induced ME Protein
Content and ME Activity in Brown Adipocytes
We have reported that ME can be induced by hormonal stimuli in
differentiating brown adipocyte primary cultures (16). Based on this,
we next examined whether PI 3-kinase plays a role in the induction of
ME in brown adipocytes treated with IGF-I. Fetal brown adipocytes were
serum-starved for 20 h and subsequently cultured for a further
24 h with 10 nM IGF-I, both in the absence and
presence of wortmannin (20 nM) or LY294002 (10
µM). At the end of the culture period, cells were lysed
and equal amounts of protein (20 µg) were submitted to Western blot
analysis with the anti-ME antibody. As shown in Fig. 4A
, upon treatment with IGF-I, a significant increase in the ME protein
content relative to untreated cells (6- to 7-fold increase) occurred,
and this effect was totally precluded in the presence of wortmannin (20
nM) or LY294002 (10 µM) together with IGF-I.
Furthermore, the changes observed in ME protein content in response to
IGF-I and PI 3-kinase inhibitors were parallel to changes in its
enzymatic activity, as shown in Fig. 4B
.

View larger version (22K):
[in this window]
[in a new window]
|
Figure 4. IGF-I-Induced ME Protein Content and ME Activity in
Fetal Brown Adipocytes: Inhibition by Wortmannin and LY294002
A, Brown adipocytes were cultured in both the absence and presence of
IGF-I and PI 3-kinase inhibitors as described in Fig. 3 . At the end of
the culture time, cells were lysed and total protein (20 µg) was
submitted to SDS-PAGE, blotted to nylon membranes, and immunodetected
with the anti-ME antibody. A representative experiment of three is
shown. B, Cells were cultured as described above. At the end of the
culture time, ME activity was determined as described in
Materials and Methods. Enzyme activity is expressed as
milliunits/mg protein and is the mean ± SEM (n =
46).
|
|
PI 3-Kinase Inhibitors Decreased Lipid Content in Fetal Brown
Adipocytes
Because wortmannin and LY294002 down-regulate the expression of
adipogenic genes and also ME activity and protein content, we studied
Nile Red fluorescence (a sensitive detector of cytoplasmic lipid
content) (29), to assess the role of PI 3-kinase in the overall
adipogenic program. Brown adipocytes were cultured as described in Fig. 3
, and at the end of the culture period Nile Red fluorescence was
analyzed in the Flow cytometer and quantitated in arbitrary units as
shown in Fig. 5
. The presence of 10 nM IGF-I
in the culture medium for 24 h significantly doubled the lipid
content detected in control cells. However, when cells were cultured
with IGF-I together with 20 nM wortmannin or 10
µM LY294002, lipid content reached a level similar to
that observed in control cells.

View larger version (19K):
[in this window]
[in a new window]
|
Figure 5. Role of PI 3-Kinase in IGF-I-Increased
Cytoplasmatic Lipid Content in Fetal Brown Adipocytes
Cells were serum-deprived for 20 h and further cultured for
24 h with 10 nM IGF-I in both the absence and presence
of various doses of wortmannin and LY294002. Cytoplasmatic lipid
content was determined by Nile Red fluorescence at the end of the
culture time. Mean intensities of Nile Red fluorescence (expressed in
arbitrary units) ± SEM from three independent experiments
are shown. Statistical analysis by Students paired t
test between values in the presence vs. in the absence
of IGF-I is represented by (*) or between IGF-I plus
wortmannin/LY294002 vs. those in the presence of IGF-I
by (); *, P < 0.01.
|
|
Wortmannin and LY294002 Inhibited UP mRNA Content in Fetal Brown
Adipocytes
Apart from its role in the adipogenic program, IGF-I is involved
in the thermogenic differentiation of brown adipocytes by inducing the
expression of the UP (17, 19). To investigate this further we examined
whether PI 3-kinase could also mediate IGF-I-induced
thermogenic-related gene expression. Accordingly, cells were cultured
for 24 h with 10 nM IGF-I in both the absence and
presence of 20 nM wortmannin and 10 µM
LY294002, and total RNA was submitted to Northern blot analysis as
shown in the representative experiment depicted in Fig. 6
. Upon treatment with IGF-I, a significant accumulation
in UP mRNA relative to control cells (cultured in the absence of IGF-I)
occurred. However, UP mRNA expression induced by IGF-I was totally
prevented when either wortmannin or LY294002 was added to the culture
medium.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 6. Wortmannin and LY294002 Down-Regulate IGF-I-Induced
UP mRNA Expression in Fetal Brown Adipocytes
Brown adipocytes were cultured in both the absence and presence of
IGF-I and PI 3-kinase inhibitors as described in Fig. 3 . At the end of
the culture time, total RNA (10 µg) was submitted to Northern blot
analysis and hybridized with labeled UP and ß-actin cDNAs. A
representative experiment of six is shown.
|
|
Effect of Rapamycin on IGF-I-Induced Differentiation-Related Gene
Expression in Brown Adipocytes
p70S6K is a ubiquitous serine/threonine kinase that is
activated by many mitogens through distinct signaling pathways (for
review see Ref.30). p70S6K has been reported to be a
molecular downstream target of PI 3-kinase (31, 32, 33). In view of the
results presented here, it was important to clarify whether
p70S6K lies in the signaling pathway that mediated
IGF-I-induced differentiation of brown adipocytes. Because the
immunosuppressant rapamycin is a selective inhibitor of
p70S6K activation in many cell types (34), we examined the
effect of rapamycin on the expression of both adipogenic and
thermogenic genes induced by IGF-I. Figure 7
is a
representative Northern blot of brown adipocytes cultured for 24 h
with 10 nM IGF-I in both the absence and presence of 25
ng/ml rapamycin, which has been proved to completely block
p70S6K activity. As shown in Fig. 7
, the expression of both
adipogenic (FAS, ME, G3PD, ACC) and thermogenic (UP) markers was partly
precluded in the presence of rapamycin compared with IGF-I-treated
brown adipocytes.

View larger version (41K):
[in this window]
[in a new window]
|
Figure 7. Effect of Rapamycin on IGF-I-Induced Adipogenic and
Thermogenic mRNA Expression in Fetal Brown Adipocytes
Brown adipocytes (after 20 h of serum starvation) were cultured
for a further 24 h with 10 nM IGF-I in both the
absence and presence of 25 ng/ml rapamycin. Control cells were cultured
without IGF-I in both the absence and presence of 25 ng/ml rapamycin.
At the end of the culture time, total RNA (10 µg) was submitted to
Northern blot analysis and hybridized with labeled FAS, ME, G3PD, ACC,
UP, and ß-actin cDNAs. A representative experiment of four is shown.
|
|
IGF-I-Induced PKC
Activity Is Inhibited by Wortmannin and
LY294002 in Brown Adipocytes
Recent data support the view that PKC
, which has recently found
to be involved in adipogenesis (35), is activated by
phosphatidylinositol 3,4,5-trisphosphate (PIP3) (36).
Furthermore PKC
is expressed in brown adipocytes, and its activity
is induced by IGF-I (20). These previous findings prompted us to
investigate whether the blockade of PI 3-kinase could interfere with
IGF-I-induced PKC
activity in brown adipocytes. Quiescent cells (20
h serum-starved) were either stimulated with IGF-I (10 nM)
for 5 min or pretreated for 15 min with 20 nM wortmannin or
10 µM LY294002 before the addition of IGF-I for a further
5 min. Then, cells were lysed and assayed for PKC
activity in the
immune complexes as described in Materials and Methods. As
shown in Fig. 8A
, myelin basic protein (MBP)
phosphorylation induced in the presence of IGF-I was totally prevented
by both wortmannin and LY294002 pretreatments and reached the basal
levels observed in control cells.
Next, we examined whether IGF-I-induced PKC
activity was
affected by the blockade of p70S6K activity. Quiescent
cells were either stimulated with IGF-I (10 nM) for 5 min
or pretreated for 15 min with 25 ng/ml rapamycin before the addition of
IGF-I for a further 5 min. Then, cells were lysed and assayed for
PKC
activity in the immune complexes. As shown in Fig. 8B
, when
fetal brown adipocytes were pretreated with the immunosuppressant
rapamycin before the addition of IGF-I, PKC
activity remained
unchanged relative to that observed in IGF-I-induced cells.
PI 3-Kinase Inhibitors Did Not Block IGF-I-Induced Mitogenesis or
Proliferating Cellular Nuclear Antigen (PCNA) Expression in Fetal Brown
Adipocytes
Based on the fact that IGF-I is a complete mitogen in fetal
brown adipocyte primary cultures (15, 17), we proceeded finally to
investigate whether PI 3-kinase inhibitors could also block
IGF-I-induced mitogenesis in our cells. Quiescent (20 h serum-starved)
brown adipocytes were cultured for 24 h with 1.4 nM
IGF-I (which maximally stimulates brown adipocyte growth) in both the
absence and presence of 20 nM wortmannin and 10
µM LY204002, and [3H]thymidine
incorporation was measured during the last 4 h of culture. As
shown in Fig. 9A
, fetal brown adipocytes cultured in the
presence of 1.4 nM IGF-I increased
[3H]thymidine incorporation by 3-fold relative to control
cells, as previously described (21). The presence of wortmannin or
LY294002 in the culture medium, together with IGF-I, did not
significantly modify the levels of [3H]thymidine
incorporation relative to those observed in IGF-I-treated
cells. Furthermore, no significant effect of PI 3-kinase inhibitors was
observed in the percentage of cells in S+G2+M phases of the cell cycle
as compared with cells stimulated with IGF-I alone (Fig. 9B
).

View larger version (28K):
[in this window]
[in a new window]
|
Figure 9. PI 3-Kinase Inhibitors Did Not Suppress
IGF-I-Induced Mitogenesis in Fetal Brown Adipocytes
A, Quiescent brown adipocytes were cultured for 24 h with 1.4
nM IGF-I in both the absence and presence of 20
nM wortmannin and 10 µM LY294002. Control
cells were cultured without IGF-I in both the absence or presence of
the same doses of inhibitors. [3H]Thymidine incorporation
into acid-insoluble material was determined during the last 4 h of
culture. Results are expressed as disintegrations per min/dish and are
means ± SEM from six independent experiments.
Statistical analysis by Students paired t test between
values in the presence of IGF-I plus wortmannin/LY294002
vs. those in the presence of IGF-I did not reveal
significance (ns). B, Cells were cultured for 24 h as described in
panel A. At the end of the culture time, the percentage of cells in
S+G2+M phases was determined as described in Materials and
Methods. Results are means ± SEM from three
independent experiments. Statistical analysis by Students paired
t test between values in the presence of IGF-I plus
wortmannin/LY294002 vs. those in the presence of IGF-I
did not reveal significance (ns). C, Brown adipocytes were cultured as
described above. At the end of the culture time, cells were lysed and
total protein (50 µg) was submitted to SDS-PAGE, blotted to a nylon
membrane, and immunodetected with the anti-PCNA monoclonal antibody. A
representative experiment of three is shown.
|
|
PCNA is a nuclear protein required for cell cycle progression and
cellular proliferation (37). In brown adipocytes treated with IGF-I,
there is an important increase of PCNA content as has recently been
described (21). Figure 9C
shows that PCNA levels induced by IGF-I
remained unchanged regardless of the presence of PI 3-kinase inhibitors
in the culture medium.
 |
DISCUSSION
|
---|
Despite recent advances in the understanding of both the function
and structure of PI 3-kinase, the precise mechanism of its involvement
in mediating IGF-I/insulin signaling is still not well understood. In
this study we have shown that two structurally different inhibitors of
PI 3-kinase, i.e. wortmannin and LY294002, blocked both the
adipogenic and thermogenic differentiation programs induced by IGF-I in
primary fetal rat brown adipocytes.
In previous reports, we have suggested that IGF-I might have a role
leading brown adipose tissue to adipogenic and thermogenic
differentiation before birth (19, 23). Furthermore, fetal brown adipose
cells bear a high number of high-affinity IGF-I receptors (17), and
this fact allowed us to characterize the very early events of the brown
adipocyte IGF-I-signaling cascade from the receptor toward the nucleus
(20). Among all of these events, PI 3-kinase enzymatic activity was
significantly activated subsequent to its association with
phosphorylated IRS-1. The results presented here demonstrate that
wortmannin, at nanomolar concentrations, dramatically inhibits
IGF-I-stimulated PI 3-kinase activity in brown adipocytes. Furthermore,
the PI 3-kinase inhibitor LY294002, which is structurally unrelated to
wortmannin, also inhibited IGF-I-stimulated PI 3-kinase activity in a
concentration-dependent manner. However, neither of these two
inhibitors disrupted other cellular events of the IGF-I-signaling
cascade upstream from PI 3-kinase activation, such as ß-chain
receptor autophosphorylation, IRS-1 tyrosine phosphorylation, and its
association with the p85 subunit of the PI 3-kinase.
Recent findings indicate that PI 3-kinase is required for the movement
of glucose transporters to the cell membrane in both white and brown
adipose tissues and in muscle cells (27, 38, 39). Moreover,
overexpression of the catalytic subunit p110
of PI 3-kinase
increases glucose transport with translocation of glucose transporters
in 3T3L1 adipocytes (40, 41). Although in fetal brown adipocyte primary
cultures we have previously described an induction of Glut4 mRNA levels
following 24 h of treatment with insulin and IGF-I (23), in this
paper we found that glucose transport increased significantly after 10
min treatment with IGF-I (20, 23), probably due to Glut4 translocation.
Both wortmannin and LY294002 impaired IGF-I-induced glucose transport
at the same concentrations at which they inhibited PI 3-kinase
activity. These results provide evidence that IGF-I-induced glucose
transport in brown adipocytes during fetal development is dependent on
PI 3-kinase activation.
It is known that IGF-I plays a dual role by inducing both mitogenesis
and differentiation in fetal brown adipocytes (17, 18, 19, 23). With regard
to differentiation, our results show that the expression of several
adipogenic genes induced by IGF-I is completely prevented by treatment
of brown adipocytes with PI 3-kinase inhibitors. The induction of ME
activity was also impaired according to its protein content. As a
result, the fat droplet content of brown adipocytes newly synthesized
in the presence of IGF-I measured by Nile red fluorescence was
significantly reduced. Because the expression of the thermogenic
differentiation marker UP is also inhibited in the presence of
wortmannin/LY294002, the results presented here implicate PI 3-kinase
activation as a crucial step in the brown adipocyte adipogenic and
thermogenic differentiation-signaling pathways.
Previous findings in confluent 3T3L1 mouse fibroblasts undergoing
insulin-induced adipogenic differentiation demonstrate that insulin
increases the ras.GTP/ras.GDP ratio (42). In addition, transforming
ras transfection induced 3T3L1 adipogenic differentiation in the
absence of IGF-I (43). On the other hand, insulin-stimulated glucose
uptake has been shown by a number of groups to be dependent on
activation of PI 3-kinase (39, 44, 45). It is not known to what extent
IRS-1/PI 3-kinase and ras.GTP reside in distinct signaling branches or
whether significant cross-talk occurs. Recently, a reciprocal
relationship between PI 3-kinase and p21-ras has been demonstrated to
exist (46, 47, 48). The fact that in brown adipocytes IGF-I increased the
expression of differentiation-related genes in parallel with an
increase in the amount of p21-ras.GTP active form (18), together with
the data presented here, gives rise to the possibility that
IRS-1-associated PI 3-kinase in conjunction with ras.GTP is required
for the signaling involved in inducing and/or maintaining the
differentiation state of brown adipocytes before birth. However, the
relative contribution of these two pathways leading to PI 3-kinase
activation and hence brown adipocyte differentiation in response to
IGF-I deserves further experimental work.
p70S6K has been identified as a molecular downstream target
of PI 3-kinase (30, 31, 32, 33). Our results demonstrate that inhibition of the
phosphorylation and activation of p70S6K with the
immunosuppressant rapamycin partly, but not totally, inhibited
IGF-I-induced adipogenic and thermogenic related gene expression. We
can therefore suggest that in addition to p70S6K, other
molecules that are activated downstream from PI 3-kinase might
participate in the molecular cascade leading to the nucleus where gene
expression is regulated. In this regard, PKC
has been shown to be
activated by the PI 3-kinase product PIP3 (36), and its
activity is induced in brown adipocytes upon IGF-I stimulation, in
parallel with cell proliferation (20). The fact that in our cells
IGF-I-induced PKC
activation is wortmannin/LY294002-sensitive
indicate that this PKC isoenzyme could be involved in the protein
network downstream from PI 3-kinase, which leads or maintains the onset
of brown adipocyte differentiation.
In addition to its role in inducing differentiation, IGF-I is a
complete mitogen in fetal brown adipocyte primary cultures by inducing
DNA synthesis, cell number increase, the entry of cells into the cell
cycle, and PCNA expression (15, 17, 21). Finally, we have demonstrated
that IGF-I-induced brown adipocyte proliferation is not inhibited by
the presence of wortmannin/LY294002 in the medium. The exact role of PI
3-kinase in regulating cell proliferation has been the subject of
controversy. It has been reported that microinjection of neutralizing
antibodies against PI 3-kinase blocks the ability of a number of growth
factors to induce DNA synthesis in fibroblasts (49). In 3T3L1
adipocytes, PI 3-kinase inhibits GTPase-activating protein, allowing
insulin to fully activate p21-ras (50). On the other hand, experiments
using wortmannin in Chinese hamster ovary (CHO) cells indicated that PI
3-kinase activity is not required for ras activation (45). In our fetal
cells IGF-I-induced mitogenesis, which has been shown to be p21
ras-dependent (20, 21), seems to be PI 3-kinase-independent.
Interestingly, it has been reported that SHC (SRC homology domain and
collagen-like) is the predominant signaling molecule that activates ras
in the insulin-signaling cascade (51, 52). SHC is tyrosine
phosphorylated following IGF-I stimulation of brown adipocytes (20).
Thus, the exact contribution of IRS-1/IRS-2, SHC, and perhaps other
docking proteins to IGF-I-induced proliferation and/or differentiation
remains to be established.
In conclusion, our results indicate that PI 3-kinase is a requirement
for the IGF-I-induced adipogenic and thermogenic differentiation
signaling pathways in fetal brown adipocytes, partly diverging through
p70S6k. However, the IGF-I-induced mitogenesis-signaling
pathway is PI 3-kinase-independent. In addition, PKC
seems to be a
signaling molecule also involved in the IGF-I-induced differentiation
pathways downstream from PI 3-kinase.
 |
MATERIALS AND METHODS
|
---|
Materials
FCS and culture media were from Imperial Laboratories
(Hampshire, UK). IGF-I, LY294002, and rapamycin were purchased from
Calbiochem (Calbiochem-Novabiochem Intl, La Jolla, CA). Wortmannin and
anti-mouse IgG-agarose were from Sigma Chemical Co. (St. Louis, MO).
Protein A-agarose was from Boehringer Mannheim (Mannheim, Germany). The
Py72 anti-Tyr(P) and the anti-
p85 subunit of PI 3-kinase mouse
monoclonal antibodies were the generous gifts of Dr. E. Rozengurt and
J. Sinnet-Smith and Drs. J. Downward and P. Rodriguez-Viciana (Imperial
Cancer Research Fundation, London), respectively. For IRS-1
immunoprecipitations, a rabbit polyclonal antibody was the generous
gift of Dr. R. Kahn (Joslin Diabetes Center, Boston, MA). The 4G10
anti-Tyr(P) monoclonal antibody was purchased from Upstate
Biotechnology (Lake Placid, NY). The anti-PCNA mouse monoclonal
antibody was purchased from Boehringer. The anti-ME polyclonal antibody
was obtained as previously described (16). For PKC
immunoprecipitations the rabbit polyclonal antiserum used was a gift of
Dr. J. Moscat (Centro de Biologia Molecular, Madrid).
[
32P]ATP (3000 Ci/mmol), [32P]dCTP (3000
Ci/mmol), 2-deoxy-D[1-3H]glucose (11.0
Ci/mmol), and [3H]thymidine (0.2 mCi/ml) were purchased
from Amersham (Aylesbury, UK). All other reagents were of the purest
grade available.
Cell Culture
Brown adipocytes were obtained from interscapular brown adipose
tissue of 20-day Wistar rat fetuses and isolated by collagenase
dispersion as previously described (17, 23). Cells were plated at
5 x 106 cells/100 mm or 11.2 x
106 cells/60-mm tissue culture plates in MEM supplemented
with 10% FCS to allow cell attachment to the plastic surface of the
plates. After 46 h of culture at 37 C, cells were rinsed twice with
PBS, and 80% of the initial cells were attached. Cells were maintained
for 20 h in a serum-free medium supplemented with 0.2% (wt/vol)
BSA. At this time, cells were treated for 5 min with IGF-I (10
nM) or preincubated for 15 min with several doses of PI
3-kinase inhibitors (wortmannin or LY294002) and subsequently
stimulated with IGF-I for a further 5 min. Both inhibitors were
initially disolved in dimethyl sulfoxide and in all experimental series
control cells were treated with the corresponding volumes of dimethyl
sulfoxide.
To analyze the effect of PI 3-kinase inhibitors on IGF-I-induced brown
adipocyte differentiation, 20 h serum-deprived cells were cultured
for a further 24 h in the presence of IGF-I either in the absence
or presence of wortmannin or LY294002 at the doses indicated in
Results and in the figure legends. Due to the instability of
wortmannin in aqueous solutions, the medium from cells treated with
wortmannin was replaced every 6 h.
Immunoprecipitations
Quiescent fetal brown adipocytes (5 x 106
cells/100-mm tissue culture dish) were treated with IGF-I for 5 min or
preincubated for 15 min with wortmannin and LY294002 and subsequently
stimulated with IGF-I for a further 5 min as indicated, and lysed at
4°C in 1 ml of a solution containing 10 mM Tris-HCl, 5
mM EDTA, 50 mM NaCl, 30 mM sodium
pyrophosphate, 50 mM NaF, 100 µM
Na3VO4, 1% Triton X-100, and 1 mM
phenylmethylsulfonyl fluoride, pH 7.6 (lysis buffer). Lysates were
clarified by centrifugation at 15,000 x g for 10 min,
and the supernatants were transferred to a fresh tube. After protein
content determination, equal amounts of protein were immunoprecipitated
at 4°C either with the monoclonal antibodies anti-Tyr(P) (Py72) and
p85, or with a polyclonal antibody against IRS-I. The immune
complexes were collected on anti-mouse IgG-agarose beads or, in the
case of the IRS-I antibody, on Protein A-agarose beads.
Immunoprecipitates were washed three times with lysis buffer and
extracted for 10 min at 95 C in 2 x SDS-PAGE sample buffer (200
mM Tris-HCl, 6% SDS, 2 mM EDTA, 4%
2-mercaptoethanol, 10% glycerol, pH 6.8) and analyzed by SDS-PAGE and
as described in Results and in the figure legends.
Western Blotting
After SDS-PAGE, proteins were transferred to Immobilon membranes
and were blocked using 5% nonfat dried milk in 10 mM
Tris-HCl and 150 mM NaCl, pH 7.5, and incubated overnight
with several antibodies as indicated in 0.05% Tween-20, 1% non-fat
dried milk in 10 mM Tris-HCl, and 150 mM NaCl,
pH 7.5. Immunoreactive bands were visualized using the enhanced
chemiluminescence (ECL) Western blotting protocol (Amersham).
In Vitro Kinase Assay
The protein kinase activity of the immunoprecipitates was
measured as described (53). The immune complexes were incubated in 20
µl of buffer containing 20 mM HEPES, 3 mM
MnCl2, 10 mM MgCl2, and 20 µCi of
[
32P]ATP (in a final concentration of 5
µM) for 15 min at room temperature. The complexes were
washed twice with cold PBS and then resuspended in 2 x SDS-PAGE
sample buffer and analyzed by SDS-PAGE. The separated proteins were
dried in the gel, and the incorporation of [32P]phosphate
into protein was visualized by autoradiography and quantitated by
scanning laser densitometry (Molecular Dynamics densitometer,
Sunnyvale, CA).
PI 3-Kinase Activity
PI 3-Kinase activity was measured by in vitro
phosphorylation of phosphatidylinositol as described (54). Fetal brown
adipocytes were incubated with IGF-I in the absence or presence of PI
3-kinase inhibitors as indicated in the figure legends. After washing
with ice-cold PBS, cells were solubilized in lysis buffer containing
leupeptin (10 µg/ml), aprotinin (10 µg/ml), and 1 mM
phenylmethylsulfonyl fluoride. Lysates were clarified by centrifugation
at 15,000 x g for 10 min at 4 C, and proteins were
immunoprecipitated with the anti-IRS-1 polyclonal antibody. The
immunoprecipitates were washed successively in PBS containing 1%
Triton X-100 and 100 µM Na3VO4
(twice), 100 mM Tris (pH 7.5) containing 0.5 M
LiCl, 1 mM EDTA and 100 µM
Na3VO4 (two times), and 25 mM Tris
(pH 7.5) containing 100 mM NaCl and 1 mM EDTA
(twice). To each pellet were added 25 µl of 1 mg/ml
L-
-phosphatidylinositol/L-
-phosphatidyl-L-serine
sonicated in 25 mM HEPES (pH 7.5) and 1 mM
EDTA.
The PI 3-kinase reaction was started by the addition of 100
nM [
32P]ATP (10 µCi) and 300
µM ATP in 25 µl of 25 mM HEPES, pH 7.4, 10
mM MgCl2, and 0.5 mM EGTA. After 15
min at room temperature, the reaction was stopped by the addition of
500 µl CHCl3-methanol (1:2) in a 1% concentration of HCl
plus 125 µl chloroform and 125 µl HCl (10 mM). The
samples were centrifuged, and the lower organic phase was removed and
washed once with 480 µl methanol-100 mM HCl plus 2
mM EDTA (1:1). The organic phase was extracted, dried
in vacuo, and resuspended in chloroform. Samples were
applied to a a silica gel TLC plate (Whatman, Clifton, NJ). TLC plates
were developed in propanol-1-acetic acid (2 N; 65:35
vol/vol), dried, visualized by autoradiography, and quantitated by
scanning laser densitometry (Molecular Dynamics personal
densitometer).
PKC
Activity
Fetal brown adipocytes either untreated or stimulated were
extracted with lysis buffer (50 mM Tris, pH 7.5, 150
mM NaCl, 1% Triton X-100, 2 mM EDTA, 1
mM EGTA, 1 mM phenylmethylsulfonyl
fluoride, 25 µg/ml leupeptin, and 25 µg/ml aprotinin) and
immunoprecipitated with an anti-PKC
antibody as previously described
(20). Immune complexes were washed seven times with ice-cold lysis
buffer with 0.5 M NaCl and twice with kinase buffer (35
mM Tris, pH 7.5, 10 mM MgCl2, 0.5
mM EGTA, and 1 mM
Na3VO4). The kinase reaction was performed in
20 µl kinase buffer containing 1 µCi [
32P]ATP, 60
µM ATP, and 1 µg MBP as a substrate for 30 min at 30 C
and was terminated by the addition of 4 x SDS-PAGE sample buffer
followed by boiling for 5 min at 95 C. Samples were resolved in 12%
SDS-PAGE, and gels were dried out and subjected to autoradiography.
Measurement of the 2-Deoxyglucose
Transport 2-Deoxyglucose transport was measured as described
(55). After culture, quiescent brown adipocytes (11.2 x
106 cells/60-mm plate) were washed three times with
Krebs-Ringer-phosphate buffer (KRP) containing 135 mM NaCl,
5.4 mM KCl, 1.4 mM CaCl2, 1.4
mM MgSO4, and 10 mM sodium
pyrophosphate, pH 7.4, and then incubated with 1 ml KRP buffer with
IGF-I for 10 min at 37 C or preincubated with PI 3-kinase inhibitors
for 15 min and subsequently stimulated with IGF-I for another 10 min.
2-Deoxy-D[1-3H]glucose was added to this
solution to a final concentration of 0.1 mM and 250 nCi/ml,
and the incubation was continued for 5 min at 37 C. The cells were then
washed three times with ice-cold KRP buffer and solubilized in 1 ml 1%
SDS. The radioactivity of a 200-µl aliquot was determined in a
scintillation counter.
Determination of ME Activity
At the end of the culture period, ME activity was measured in
the cytosolic supernatants as previosly described (16). Enzyme activity
was expressed as milliunits/mg of protein. A milliunit is nanomoles
NADPH formed/min.
Flow Cytometric Analysis of Nile Red Fluorescence
Cytoplasmatic lipid content was determined by Nile Red
fluorescence emission 530 (BP 530/30 nm) in a FACScan flow cytometer
(Becton-Dickinson, San Jose, CA). Cells were detached from dishes by
addition of 0.05% trypsin-0.02% EDTA, and lipid content was
determined in aliquots of 2 x 105 cells after the
addition of Nile Red (0.1 µg/ml) (56). Results represent mean
intensities of fluorescence (obtained from the histograms of numbers of
cells vs. intensity of fluorescence) and are expressed in
arbitrary units.
RNA Extraction and Analysis
At the end of the culture time, cells were washed twice with
ice-cold PBS, and RNA was isolated with RNazol B (Biotecx Lab, Dallas,
TX) following the protocol supplied by the manufacturer for total RNA
isolation (57). Total cellular RNA (10 µg) was submitted to Northern
blot analysis, i.e . electrophoresed on 0.9% agarose gels
containing 0.66 M formaldehyde, transferred to GeneScreen
(NEN Research Products, Boston, MA) membranes using a VacuGene blotting
apparatus (LKB-Pharmacia, Upsala, Sweden). Hybridization was in 0.25
mM NaHPO4, pH 7.2, 0.25 M NaCl, 100
µg/ml denatured salmon sperm DNA, 7% SDS, and 50% deionized
formamide, containing denatured 32P-labeled cDNA
(106 cpm/ml) for 24 h at 42 C. Complementary DNA
labeling was carried out with [32P]dCTP to a specific
activity of 109 cpm/µg of DNA by using multiprimer
DNA-labeling system kit. For serial hybridization with different
probes, the blots were stripped and rehybridized subsequently as needed
in each case. The cDNAs used as probes were FAS (58), ME (59), G3PD
(60), ACC (61), UP (62), and ß-actin (63). Membranes were subjected
to autoradiography, and relative densities of the hybridization signals
were determined by densitometric scanning of the autoradiograms.
Determination of [3H]Thymidine
Incorporation into Acid-Insoluble Material
DNA synthesis was determined after 24 h of cell culture in
the presence of IGF-I (1.4 nM) in the absence or presence
of PI 3-kinase inhibitors by [3H]thymidine incorporation
(0.2 mCi/ml) into acid-insoluble material during the last 4 h of
culture (15). Results are expressed as disintegrations per
min/dish.
Cell Cycle Analysis by Flow Cytometry
After culture of cells for 24 h in the presence of IGF-I
without or with PI 3-kinase inhibitors, cells were detached from plates
by addition of 0.05% trypsin-0.02% EDTA. Trypsinization was stopped
by addition of 10% FCS to the culture medium. The percentages of cells
in G0/G1 and in S+G2+M phases of the cell cycle were determined after
nuclei were stained with propidium iodine by using the Cycle test DNA
reagent kit (Becton-Dickinson, San Jose, CA), measured in a Double
Discriminator Module and computer analyzed. All measurements were
performed in a FACScan flow cytometer (Becton-Dickinson).
Protein Determination
Protein determination was performed by the Bradford dye method
(64), using the Bio-Rad reagent (Bio-Rad, Richmond, CA) and BSA as the
standard.
Experimental Animals
The animals used for the required experiments in this report
were treated in accord with the "Guidelines for Care and Use of
Experimental Animals."
 |
ACKNOWLEDGMENTS
|
---|
We are grateful for valuable reagents provided by Drs. E.
Rozengurt, J. Downward, P. Rodriguez-Viciana, J. Sinnet-Smith (Imperial
Cancer Research Foundation, London); Dr. R. Kahn (Joslin Diabetes
Center, Boston); and Dr. J. Moscat (Centro de Biologia Molecular,
Madrid). We thank Dr. A. Alvarez for his expert technical assistance
with the flow cytometer.
 |
FOOTNOTES
|
---|
Address requests for reprints to: Manuel Benito, Departamento de Bioquimica y Biologia Molecular II, Instituto de Bioquimica, Facultad de Farmacia, Universidad Complutense, 28040 Madrid Spain.
This work was supported by a SAF 96/0115 Grant from the Comision
Interministerial de Ciencia y Tecnologia, Spain. P. Navarro was a
recipient of a fellowship from the Ministerio de Educacion y Ciencia,
Spain.
Received for publication December 5, 1996.
Revision received February 6, 1997.
Accepted for publication February 12, 1997.
 |
REFERENCES
|
---|
-
Humbel RE 1990 Insulin-like growth factors I and II. Eur
J Biochem 190:445462[Medline]
-
LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT 1995 Molecular and cellular aspects of the insulin-like growth factor
receptor. Endocr Rev 16:143163[Medline]
-
White MF, Marron R, Kahn CR 1985 Insulin rapidly stimulates
phosphorylation of a Mr 185,000 protein in intact cells. Nature 318:183186[Medline]
-
Izumi T, White MF, Kadowaki T, Takaku F, Akanuma Y, Kasuga M 1987 Insulin-like growth factor I rapidly stimulates tyrosine
phosphorylation of a Mr 185,000 protein in intact cells. J Biol
Chem 262:12821287[Abstract/Free Full Text]
-
Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA,
Cahill DA, Goldstein BJ White MF 1991 Structure of the insulin receptor
substrate IRS-1 defines a unique signal transduction protein. Nature 352:7377[CrossRef][Medline]
-
Giorgetti S, Ballotti R, Kowalski-Chauvel A, Tartare S, Van
Obberghen E 1993 The insulin and insulin-like growth factor-I receptor
substrate IRS-1 associates with and activates phosphatidylinositol
3-kinase in vitro. J Biol Chem 268:73587364[Abstract/Free Full Text]
-
Backer JM, Myers Jr MG, Shoelson SE, Chin DJ, Sun XJ,
Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J, White MF 1992 The phosphatidylinositol 3-kinase is activated by association with
IRS-1 during insulin stimulation. EMBO J 11:34693479[Abstract]
-
Myers Jr MG, Backer JM, Sun XJ, Shoelson SE, Hu P,
Schlessinger J, Yoakim M, Schaffhausen B, White MF 1992 IRS-1 activates
the phosphatidylinositol 3'kinase by associating with the src homology
2 domains of p85. Proc Natl Acad Sci USA 89:1035010354[Abstract]
-
Otsu M, Hiles I, Gout I, Fry MJ, Ruiz-Larrea F,
Panayotou G, Thompson A, Dhand R, Hsuan J, Totty N, Waterfield M 1991 Characterization of two 85 kDa proteins that associate with receptor
tyrosine kinases, middle-T/pp60c-src complexes and PI3-kinase. Cell 65:91104[Medline]
-
Hiles ID, Otsu M, Volinis S Fry MJ, Gout I, Dhand R, Panayotou
G, Ruiz-Larrea F, Thompson A, Totty NF, Watterfield M 1992 Phosphatidylinositol 3-kinase structure and expression of the 110 kDa
catalytic subunit. Cell 70:419429[Medline]
-
Stephens LR, Jackson TR, Hawkins PT 1993 Agonist-stimulated
synthesis of phosphatidylinositol(3, 4, 5)-trisphosphate: a new
intracellular signalling system. Biochim Biophys Acta 1179:2775[Medline]
-
Downes CP, Carter AN 1991 Phosphoinositide 3-kinase: a new
effector in signal transduction. Cell Signal 3:501503[CrossRef][Medline]
-
Hawkins PT, Jackson TR, Sthephens LR 1992 Platelet-derived
growth factor stimulates synthesis of PtdIns'(3, 4, 5)P3 by activating
PtdIns(4, 5)P2 3-OH kinase. Nature 358:157159[CrossRef][Medline]
-
Kaliman P, Viñals F, Testar X, Palacín M,
Zorzano A 1996 Phosphatidylinoditol 3-kinase inhibitors block
differentiation of skeketal muscle cells. J Biol Chem 271:1914619151[Abstract/Free Full Text]
-
Valverde AM, Benito M, Lorenzo M 1991 Proliferation of fetal
brown adipocyte primary cultures:relationship with the genetic
expression of glucose 6-phosphate dehydrogenase. Exp Cell Res 194:232237[Medline]
-
Valverde AM, Benito M, Lorenzo M 1992 Hormonal regulation of
malic enzyme and glucose 6-phosphate dehydrogenase in fetal brown
adipocyte primary cultures. Eur J Biochem 203:313319[Abstract]
-
Lorenzo M, Valverde AM, Teruel T, Benito M 1993 IGF-I is a
mitogen also involved in differentiation-related gene expression in
fetal rat brown adipocytes. J Cell Biol 123:15671575[Abstract]
-
Lorenzo M, Valverde AM, Teruel T, Alvarez A, Benito M 1996 p21-ras induced differentiation-related gene expression in fetal brown
adipocyte primary cells and cell lines. Cell Growth Differ 7:12511259[Abstract]
-
Teruel T, Valverde AM, Benito M, Lorenzo M 1995 Differentiation of rat brown adipocytes during late foetal development:
role of insulin-like growth factor I. Biochem J 310:771776[Medline]
-
Valverde AM, Teruel T, Lorenzo M, Benito M 1996 Involvement of
Raf-1 kinase and protein kinase C
in insulin-like growth factor
I-induced brown adipocyte mitogenic signaling cascades: inhibition
by cyclic adenosine 3',5'-monophosphate. Endocrinology 137:38323841[Abstract]
-
Valverde AM, Lorenzo M, Teruel T, Benito M 1995 cAMP
inhibits IGF-I-induced mitogenesis in fetal rat brown adipocytes: role
of p21 ras. Exp Cell Res 218:305309[CrossRef][Medline]
-
Ailhaud G, Grimaldi P, Nègrel R 1992 Cellular and
molecular aspects of adipose tissue development. Annu Rev Nutr 12:207233[CrossRef][Medline]
-
Teruel T, Valverde AM, Benito M, Lorenzo M 1996 Insulin-like
growth factor I and insulin induce adipogenic-related gene expression
in foetal brown adipocyte primary cultures. Biochem J 319:627632[Medline]
-
Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y,
Nonomura Y, Matsuda Y 1993 Inhibition of histamine secretion by
wortmannin through the blockade of phosphatidylinositol 3-kinase in
RBL-2H3 cells. J Biol Chem 268:2584625856[Abstract/Free Full Text]
-
Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M 1994 Essential
role of phosphatidylinositol 3-kinase in insulin-induced glucose
transport and antilipolysis in rat adipocytes J Biol Chem 269:35683573[Abstract/Free Full Text]
-
Vlahos CJ, Matter WF, Hui KY, Brown RF 1994 A spe-cific
inhibitor of phosphatidylinositol 3-kinase,
2-(4morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol
Chem 269:52415248[Abstract/Free Full Text]
-
Schimizu Y, Schimazu T 1994 Effects of wortmannin in increased
glucose transport by insulin and norepinephrine in primary cultures of
brown adipocytes. Biochem Biophys Res Commun 202:660665[CrossRef][Medline]
-
Kimura K, Hattori S, Kabuyama Y, Shizawa Y, Takayanagi J,
Nakamura S, Toki S, Matsuda Y, Onodera K, Fukui Y 1994 Neurite
outgrowth of PC12 cells is suppressed by wortmannin, a specific
inhibitor of phosphatidylinositol 3-kinase. J Biol Chem 269:1896118967[Abstract/Free Full Text]
-
Smyth MJ, Wharton W 1992 Differentiation of A31T6
proadipocytes to adipocytes: a flow cytometric analysis. Exp Cell Res 199:2938[Medline]
-
Proud CG 1996 p70 S6 kinase: an enigma with variations. Trends
Biochem Sci 21:181185[CrossRef][Medline]
-
Ming X-F, Burgering BMT, Wennstrom S, Claesson-Welsh L, Heldin
C-H, Bos Jl, Kozma SC, Thomas G 1994 Activation of p70/p85 S6 kinse by
a pathway independent of p21ras. Nature 271:426429
-
Chung J, Grammer TC, Lemon KP, Kazlauuskas A, Blenis J 1994 PDGF- and insulin-dependent pp70S6K activation
mediated by phosphatidylinositol 3-OH kinase. Nature 370:7175[CrossRef][Medline]
-
Weng QP, Andrabi K, Klippel A, Kozlowski MT, Williams LT,
Avruch J 1995 Phosphatidylinositol 3-kinase signals activation of p70
S6 kinase in situ through site-specific p70 phosphorylation.
Proc Natl Acad Sci USA 92:57445748[Abstract]
-
Ferrari S, Bannwarth W, Morley SJ, Totty NF, Thomas G 1992 Activation of p70 S6L is associated with phosphorylation of four
clustered sites displaying Ser/Thr-Pro motifs. Proc Natl Acad Sci USA 89:72827285[Abstract]
-
LaCasa D, Agli B, Giudicelli Y 1995 Zeta PKC in rat
preadipocytes:modulation by insulin and serum mitogenic factors and
possible role in adipogenesis. Biochem Biophys Res Commun 217:123130[CrossRef][Medline]
-
Nakanishi H, Brewer KA, Exton J 1993 Activation of the
isoenzyme of protein kinase C by phosphatidylinositol
3,4,5-trisphosphate. J Biol Chem 268:1316[Abstract/Free Full Text]
-
Baserga R 1991 Growth regulation of the PCNA gene. J Cell Sci 98:433436[Medline]
-
Omatsu-Kanbe M, Kitasato H 1992 Insulin and noradrenaline
independently stimulate the translocation of glucose transporters from
intracellular stores to the plasma membrane in mouse brown adipocytes.
FEBS Lett 314:246250[CrossRef][Medline]
-
Berger J, Hayes N, Szalkowski DM, Zhang B 1994 PI3-kinase
activation is required for insulin stimulation of glucose transport
into L6 myotubes. Biochem Biophys Res Commun 205:570576[CrossRef][Medline]
-
Martin S, Haruta T, Morris AJ, Klippel A, Williams LT, Olefsky
JM 1996 Activated phosphatidylinositol 3-kinase is sufficient to
mediate actin rearrangement and GLUT4 translocation in 3T3L1
adipocytes. J Biol Chem 271:1760517608[Abstract/Free Full Text]
-
Katagiri H, Asano T, Ishihara H, Inukai K, Shibasaki Y,
Kikuchi M, Yakazi Y, Oka Y 1996 Overexpression of catalytic subunit
p110
of phosphatidylinositol 3-kinase increases glucose transport
activity with translocation of glucose transporters in 3T3L1
adipocytes. J Biol Chem 271:1698716990[Abstract/Free Full Text]
-
Porras A, Nebreda AR, Benito M, Santos E 1992 Activation of
ras by insulin in 3T3L1 cells does not involve GTPase-activating
protein phosphorylation. J Biol Chem 267:2112421131[Abstract/Free Full Text]
-
Benito M, Porras A, Nebreda AR, Santos E 1991 Differentiation
of 3T3L1 fibroblasts to adipocytes induced by transformation of ras
oncogenes. Science 253:565568[Medline]
-
Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J Kahn RC 1994 Phosphatidylinositol 3-kinase activation is required for insulin
stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter
translocation. Mol Cell Biol 14:49024911[Abstract]
-
Hara K, Yonezawa K, Sakaue H, Ando A, Kotani K, Kitamura
T, Kitamura Y, Ueda H, Stephens L, Jackson TR 1994 Phosphatidylinositol
3-kinase activity is required for insulin-stimulated glucose transport
but not for Ras activation in CHO cells. Proc Natl Acad Sci USA 91:74157419[Abstract]
-
Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeeck B,
Gout I, Fry MJ, Waterfield MD, Downward J 1994 Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527532[CrossRef][Medline]
-
Rodrigez-Viciana P, Warne PH, Vanhaesebroeeck B, Waterfield
MD, Downward J 1996 Activation of phosphoinositide 3-kinase by
interaction with ras and by point mutation. EMBO J 15:24422451[Abstract]
-
Hu Q, Klippel A, Muslin AJ, Fantl WJ, Williams LT 1995 Ras-dependent induction of cellular responses by constitutively active
phosphatidylinositol-3 kinase. Science 268:100102[Medline]
-
Roche S, Koeegl M, Courtneidge SA 1994 The
phosphatidylinositol 3-kinase
is required for DNA synthesis induced
by some, but not all, growth factors. Proc Natl Acad Sci USA 91:91859189[Abstract]
-
DePaolo D, Reusch Je, Carel K, Bhuripanyo P, Leitner JW,
Draznin B 1996 Functional interactions of phosphatidylinositol
3-kinase with GTPase-activating protein in 3T3L1 adipocytes. Mol Cell
Biol 16:14501457[Abstract]
-
Ouwens DM, Van der Zon GCM, Pronk GJ, Bos JL, Moller W,
Cheatham B, Kahn CR, Maassen JA 1994 A mutant insulin receptor induces
formation of a Shc-growth factor receptor bound protein 2 (Grb2)
complex and p21ras-GTP without detectable interaction of insulin
receptor substrate 1 (IRS-1) with Grb2. J Biol Chem 269:3311633122[Abstract/Free Full Text]
-
Sasaoka T, Draznin B, Leitner JW, Langlois WJ, Olefsky JM 1994 Shc is the predominant signaling molecule coupling insulin receptors to
activation of guanine nucleotide releasing factor and p21 ras-GTP
formation. J Biol Chem 269:1073410738[Abstract/Free Full Text]
-
Lam K, Carpenter CL, Ruderman NB, Friel JC, Kelly KL 1994 The
phosphatidylinositol 3-kinase serine phosphorylates IRS-1. J Biol
Chem 269:2064820652[Abstract/Free Full Text]
-
Reif K, Gout I, Waterfield MD, Cantrell DA 1993 Divergent
regulation of phosphatidylinositol 3-kinase P85
and P85ß isoforms
upon T cell activation. J Biol Chem 268:1078010788[Abstract/Free Full Text]
-
Rice KM, Garner CW 1994 Correlation of the insulin receptor
substrate-1 with insulin-responsive deoxyglucose transport in 3T3L1
adipocytes. Biochem Biophys Res Commun 198:523530[CrossRef][Medline]
-
Greespan P, Mayer EP, Fawles SD 1985 A selective fluorescent
stain for intracellular lipid droplets. J Cell Biol 100:965973[Abstract]
-
Chomczynski P, Sacchi N 1987 Single-step method of RNA
isolation by acid guanidium thyocianate-phenol-chloroform extraction.
Anal Biochem 162:156159[CrossRef][Medline]
-
Amy CM, Witkowski A, Naggert J, Williams B, Randhawa Z, Smith
S 1989 Molecular cloning and sequencing of cDNAs encoding the entire
rat fatty acid synthase. Proc Natl Acad Sci USA 86:31143118[Abstract]
-
Magnuson MA, Nikodem VM 1983 Molecular cloning of a cDNA
sequence for rat malic enzyme. J Biol Chem 258:1271212717[Abstract/Free Full Text]
-
Ireland RC, Kotarski MA, Johnston LA, Stadler U,
Birkenmeier E, Kozak LP 1986 Primary structure of the mouse
glycerol-3-phosphate dehydrogenase gene. J Biol Chem 261:1177911785[Abstract/Free Full Text]
-
Luo X, Park K, Lopez-Casillas F, Kim K-H 1989 Structural
features of the acetyl-CoA carboxylase gene: mechanisms for the
generation of mRNAs with 5'end heterogeneity. Proc Natl Acad Sci USA 86:40424046[Abstract]
-
Bouillaud F, Ricquier D, Thibault J, Weissenbach J 1985 Molecular approach to thermogenesis in brown adipose tissue: cDNA
cloning of the mitochondrial uncoupling protein. Proc Natl Acad Sci USA 82:445448[Abstract]
-
Cleveland D, Lopata MA, Mac Donald RJ, Cowan NJ, Rutter WJ,
Kirschner MW 1980 Number and evolutionary conservation of
- and
ß-tubulin and cytoplasmatic ß- and
-actin genes using specific
cloned cDNA probes. Cell 20:95105[Medline]
-
Bradford M 1976 A rapid and sensitive method for the
quantitation of microgram quantities utilizing the principle of
protein dye binding. Anal Biochem 72:248254[CrossRef][Medline]